NCT06778187
- Conditions
- Acute Myeloid Leukemia, Anemia, Anemia, Refractory, +20 more
- Locations
-
- Queen Mary Hospital, Hong Kong Hong Kong
Clinical trial condition
Anemia, Refractory
Explore clinical trials studying Anemia, Refractory. Study availability and eligibility vary by location and protocol.
188 public trials
35 recruiting studies
Anemia, Refractory trial results
Recruiting
Anti-NKG2A Monoclonal Antibody for AML or MDS Patients Undergoing Haploidentical Transplantation
NCT06892223
- Conditions
- Acute Myeloid Leukaemia, Anemia, Anemia, Refractory, +13 more
- Locations
-
- IRCCS Ospedale Policlinico San Martino Genova, GENOVA, Italy
- Irccs Istituto Clinico Humanitas Rozzano, MILANO, Italy
NCT06785077
- Conditions
- Adnexal Diseases, Anemia, Anemia, Refractory, +28 more
- Locations
-
- Istituto Europeo di Oncologia Milan, Italy
NCT04741945
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +10 more
- Locations
-
- Rigshospitalet Copenhagen, Copenhagen N, Denmark
NCT06111612
- Conditions
- Acute Myeloid Leukemia, Anemia, Anemia, Refractory, +23 more
- Locations
-
- Shanghai General Hospital Shanghai, Shanghai Municipality, China
Not Yet Recruiting
PRAISE-IR Versus CIBMTR Controls
NCT07717164
- Conditions
- ALL (Acute B-Lymphoblastic Leukemia), AML (Acute Myeloid Leukemia), Anemia, +12 more
- Locations
-
- Memorial Sloan Kettering Cancer center New York, United States
Not Yet Recruiting
Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic Malignancies
NCT07710781
- Conditions
- Acute Biphenotypic Leukemia, Acute Leukemia, Acute Lymphoblastic Leukemia, +42 more
- Locations
-
Not specified
Not Yet Recruiting
Forecasting Relapse Outcomes With AlloHeme-based Risk Detection in Post-Allo-HCT AML/MDS Patients (FORWARD)
NCT07607327
- Conditions
- AML (Acute Myelogenous Leukemia), Anemia, Anemia, Refractory, +16 more
- Locations
-
- CareDx, Inc. Brisbane, California, United States
Not Yet Recruiting
Dresden MDS Registry With an Accompanying Biomaterial Collection
NCT07561385
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +8 more
- Locations
-
- Universitätsklinikum Carl Gustav Carus Dresden Dresden, Germany
Not Yet Recruiting
A Long-term Follow-up Study of Patients With ARD103 CAR-T Cell Therapies
NCT06906380
- Conditions
- Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia, in Relapsed or Refractory, Anemia, +12 more
- Locations
-
- Novant Health Cancer Institute Charlotte, North Carolina, United States
- Novant Health Cancer Institute Winston-Salem, North Carolina, United States
- MD Anderson Cancer Center Houston, Texas, United States